• 4119 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

I am an Assistant Professor of Urology at the Northwestern University Feinberg School of Medicine, as well as Section Chief of Robotic Surgery at the Jesse Brown VA Medical Center. I received his MD and PhD degrees from Northwestern University in 2005, completed my urology residency at Northwestern University in 2011, and a urologic oncology fellowship at Memorial Sloan-Kettering Cancer in 2012. My clinical efforts focus on minimally invasive and open urologic oncology with a particular interest in bladder and prostate cancer. My research interests focus on both the epigenetics and genetic mutations associated with cancer biology. Specifically,I am studying how chromatin remodeling genes play a role in bladder cancer. In addition, I am studying the “driver” mutations found in bladder cancer. In the future, I hope to develop novel systemic and intravesical therapies to improve survival of patients with bladder cancer.

Certifications and Licenses


Training Experience

2006Internship, Northwestern University, Feinberg School of Medicine
2011Residency, Northwestern University, Feinberg School of Medicine
2012Fellowship, Memorial Sloan-Kettering Cancer Center

Education/Academic qualification

MD, Northwestern University, Feinberg School of Medicine

… → 2005

PhD, Northwestern University, Feinberg School of Medicine

… → 2003

Research interests

  • Big Data
  • Bioinformatics
  • Bladder Cancer
  • Bladder and Urinary Tract
  • Genetics
  • Immunogenetics
  • Immunology
  • Oncology
  • Robotic Surgery
  • Translational Research
  • Urology

Fingerprint Dive into the research topics where Joshua J Meeks is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Adaptive immune resistance to intravesical BCG in non–muscle invasive bladder cancer: Implications for prospective BCG-unresponsive trials

Kates, M., Matoso, A., Choi, W., Baras, A. S., Daniels, M. J., Lombardo, K., Brant, A., Mikkilineni, N., McConkey, D. J., Kamat, A. M., Svatek, R. S., Porten, S. P., Meeks, J. J., Lerner, S. P., Dinney, C. P., Black, P. C., McKiernan, J. M., Anderson, C., Drake, C. G. & Bivalacqua, T. J., Feb 15 2020, In : Clinical Cancer Research. 26, 4, p. 882-891 10 p.

Research output: Contribution to journalArticle

  • 8 Scopus citations

    Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma

    Podojil, J. R., Glaser, A. P., Baker, D., Courtois, E. T., Fantini, D., Yu, Y., Eaton, V., Sivajothi, S., Chiang, M., Das, A., McLaughlin, K. A., Robson, P., Miller, S. D. & Meeks, J. J., Jan 1 2020, In : OncoImmunology. 9, 1, 1744897.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer

    Cooley, L. F., McLaughlin, K. A. & Meeks, J. J., Feb 2020, In : Urologic Clinics of North America. 47, 1, p. 35-46 12 p.

    Research output: Contribution to journalReview article

  • 1 Scopus citations